Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Interest Expenses (2022 - 2025)

Gossamer Bio's Interest Expenses history spans 4 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Interest Expenses changed 0.47% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $11.0 million, down 4.58%, while the annual FY2025 figure was $11.0 million, 4.58% down from the prior year.
  • Interest Expenses reached $2.8 million in Q4 2025 per GOSS's latest filing, roughly flat from $2.7 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $3.5 million in Q1 2023 to a low of $2.7 million in Q3 2024.
  • Average Interest Expenses over 4 years is $3.1 million, with a median of $3.2 million recorded in 2023.
  • Peak YoY movement for Interest Expenses: increased 0.95% in 2023, then fell 18.22% in 2024.
  • A 4-year view of Interest Expenses shows it stood at $3.5 million in 2022, then decreased by 6.31% to $3.2 million in 2023, then fell by 15.47% to $2.7 million in 2024, then rose by 0.47% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Interest Expenses are $2.8 million (Q4 2025), $2.7 million (Q3 2025), and $2.7 million (Q2 2025).